Cozaar and Minitran drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cozaar (losartan potassium) and Minitran (nitroglycerin). Common drug interactions include joint swelling among females and coronary artery disease among males.

The phase IV clinical study analyzes what interactions people have when they take Cozaar and Minitran. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Cozaar?

Cozaar has active ingredients of losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 45,124 Cozaar users. Check the latest studies of Cozaar.

What is Minitran?

Minitran has active ingredients of nitroglycerin. eHealthMe is studying from 950 Minitran users. Check the latest studies of Minitran.

On Jul, 16, 2026

14 people who take Cozaar and Minitran together, and have interactions are studied.

What are the common drug interactions of Cozaar and Minitran, by gender? *:

female:

Joint swelling
Nausea (feeling of having an urge to vomit)
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Back pain
Blood sodium decreased
Chronic kidney disease
Confusional state
Constipation
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Dehydration (dryness resulting from the removal of water)

male:

Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Cough
Blood lactate dehydrogenase increased
Blood myoglobin increased
Bradycardia (abnormally slow heart action)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Chest pain
Diabetes mellitus inadequate control
Dry skin
Dysphonia (speech disorder attributable to a disorder of phonation)

What are the common drug interactions of Cozaar and Minitran, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Abdominal pain upper
Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
Anxiety
Aortic atherosclerosis (degenerative process of aortic arteries)
Astigmatism (refractive error of the eye in which parallel rays of light from an external source do not converge on a single focal point on the retina)
Blood cholesterol increased
Bradycardia (abnormally slow heart action)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Chest pain

60+:

Joint swelling
Nausea (feeling of having an urge to vomit)
Constipation
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Cough
Dehydration (dryness resulting from the removal of water)
Dizziness
Dysphagia (a condition in which swallowing is difficult or painful)
Dysphonia (speech disorder attributable to a disorder of phonation)
Fall

What are the existing conditions these people have? *

Diabetes: 2 people, 14.29%
Tremor (trembling or shaking movements in one or more parts of your body): 1 person, 7.14%
Thyroid Diseases: 1 person, 7.14%
Osteoporosis (bones weak and more likely to break): 1 person, 7.14%
Lung Infection: 1 person, 7.14%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 7.14%
Dizziness: 1 person, 7.14%
Depression: 1 person, 7.14%
Conjunctivitis Infective (infection of the conjunctiva): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Cozaar and Minitran?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously